Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Gastar Exploration Limited (USA) (GST)

Page 1 of 2

Many investors, including Carl Icahn or Stan Druckenmiller, have been saying for a while now that the current market is overvalued due to a low interest rate environment that leads to companies swapping their equity for debt and focusing mostly on short-term performance such as beating the quarterly earnings estimates. In the third quarter, many investors lost money due to unpredictable events such as the concerns over Valeant’s drug pricing policy that led to an overall drop among pharma stocks. Nevertheless, many of the stocks that tanked in the third quarter still sport strong fundamentals and their decline was more related to the general market sentiment rather than their individual performance and hedge funds kept their bullish stance. In this article we will find out how hedge fund sentiment to Gastar Exploration Limited (USA) (NYSEMKT:GST) changed recently.

Gastar Exploration Limited (USA) (NYSEMKT:GST) shareholders have witnessed a decrease in hedge fund interest recently. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as GSI Technology, Inc. (NASDAQ:GSIT), and Symmetry Surgical Inc (NASDAQ:SSRG) to gather more data points.

Follow Gastar Exploration Ltd (NYSEMKT:GST)
Trade (NYSEMKT:GST) Now!

In the eyes of most traders, hedge funds are viewed as slow, outdated financial vehicles of yesteryear. While there are over 8000 funds trading at present, our researchers look at the aristocrats of this group, approximately 700 funds. These money managers control the lion’s share of the smart money’s total asset base, and by observing their highest performing stock picks, Insider Monkey has come up with a number of investment strategies that have historically surpassed the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy defeated the S&P 500 index by 12 percentage points a year for a decade in their back tests.

Now, let’s view the fresh action encompassing Gastar Exploration Limited (USA) (NYSEMKT:GST).

How have hedgies been trading Gastar Exploration Limited (USA) (NYSEMKT:GST)?

At the end of the third quarter, a total of 6 of the hedge funds tracked by Insider Monkey held long positions in this stock, a decrease of 33% from one quarter earlier. With hedge funds’ capital changing hands, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their holdings meaningfully (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Israel Englander’s Millennium Management has the largest position in Gastar Exploration Limited (USA) (NYSEMKT:GST), worth close to $1.8 million, corresponding to less than 0.1% of its total 13F portfolio. On Millennium Management’s heels is Citadel Investment Group, managed by Ken Griffin, which holds a $0.7 million position; the fund has less than 0.1% of its 13F portfolio invested in the stock. Other members of the smart money with similar optimism contain Gregory Fraser, Rudolph Kluiber, and Timothy Krochuk’s GRT Capital Partners, Chao Ku’s Nine Chapters Capital Management, and D E Shaw.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!